Canada· CA-DIN-02449560
AURO-ZIPRASIDONE
A ziprasidone product containing ziprasidone (ziprasidone hydrochloride monohydrate), registered in Canada by AURO PHARMA INC. The same ATC class is registered in 14 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Ziprasidone is registered in 14 of 19 countries.
Countries holding a registration under ATC N05AE04 (ziprasidone), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Ziprasidone · ATC N05AE04
14 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ziprasidone costs, country by country.
Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ziprasidone · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- US United States$0.54 (acquisition cost)
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE)
- Manufacturer
- AURO PHARMA INC
- Country
- Canada (CA)
- ATC code
- N05AE04
- ATC class
- Ziprasidone
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
403 interactions on record for ziprasidone.
Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ziprasidone · interactions on record
403 records
- 147 severe
- 162 moderate
- 38 minor
- 56 info
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ziprasidone in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGeodonViatris Specialty LLC
- SpainZELDOX 60 mg CAPSULAS DURASViatris Healthcare Limited
- SwedenZeldox 60 mg Kapsel, hårdViatris Healthcare Limited
- FinlandZeldoxViatris Healthcare Limited
- CzechiaZELDOXVIATRIS HEALTHCARE LIMITED, Dublin
- IrelandGeodon 60mg capsules, hardUpjohn EESV
- IcelandZeldoxViatris ApS
- NorwayZiprasidon ActavisActavis Group PTC ehf
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Zeldox, Ziprasidon Krka
- Bulgaria · Зелдокс, Зипсила
- Cyprus · Geodon
- Czechia · Zeldox, Zypsilan
- Germany · Zeldox, Ziprasidon 1 A Pharma
- Denmark · Zeldox, Ziprasidon Krka
- Spain · Zeldox, Ziprasidona Aurovitas
- Finland · Zeldox, Ziprasidon Krka
- Greece · Geodon, Ziprasidone Actavis
- Croatia · Zeldox
- Hungary · Ypsila, Zeldox
- Ireland · Geodon
- Iceland · Zeldox, Ziprasidon Actavis
- Italy · Zeldox, Ziprasidone Sandoz
- Lithuania · Zeldox, Zypsilan
- Latvia · Ypsila, Zeldox
- Malta · Ziprasidone Aurobindo
- Norway · Zeldox, Ziprasidon Actavis
- Poland · Zypsila
- Portugal · Zeldox, Ziprasidona Aurobindo
- Romania · Zypsila
- Sweden · Zeldox, Ziprasidon Actavis
- Slovenia · Zeldox, Zypsila
- Slovakia · Zeldox, Zipwell
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/023919ed-b20e-4615-9cbf-dda3ddfd2980 GET /v1/drugs/023919ed-b20e-4615-9cbf-dda3ddfd2980?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02449560",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N05AE04",
"schedule": [
"Prescription"
],
"drug_code": "93539",
"strengths": [
"60 MG"
],
"ahfs_class": null,
"substances": [
"ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE)"
],
"product_categorization": null
}See everything about ziprasidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.